Skip to main content

Table 1 Treatment regimen of LTBI patients upon registration (2016–2017)

From: Trend and treatment outcomes of latent tuberculosis infection among migrant persons in Japan: retrospective analysis of Japan tuberculosis surveillance data

 

Japan-born

Foreign-born

n

%

n

%

INH monotherapy

12,298

96.0

1309

92.3

RFP monotherapy

225

1.8

78

5.5

No treatment

235

1.8

27

1.9

Othersa

59

0.5

4

0.3

TOTAL

12,817

100.0

1418

100.0

  1. INH isoniazid, RFP rifampicin a“Others” consist of all other treatment categories, excluding “no treatment” – please see Annex (S1 Appendix)
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us